continuing to boost Gilead's sales growth beyond then. We expect competition from AbbVie and Bristol, and data from Merck at the annual meeting of the American Association for the Study of Liver Diseases in November indicate that the firm could
Merck 's internal research and development has ..... a major threat from generic competition. Merck 's restructured and more focused R&D programs ..... should yield increased productivity. We give Merck KGaA a standard stewardship rating. Since
We plan to raise Merck KGaA's fair value estimate slightly on ..... segment and will be immediately accretive to Merck 's earnings. AZ Electronic Materials ..... trailing 12 months, which would increase Merck 's adjusted EBITDA by approximately 6
Forest Laboratories ( FRX ) is paying $240 million to Merck ( MRK ) for exclusive U.S. rights to schizophrenia drug Saphris ..... slightly lower than the $166 million it achieved in 2012. Merck , which acquired Saphris through its merger with Schering
FRANKFURT/LONDON, Dec 5 (Reuters) - Merck , the world's largest maker of liquid crystals used in TVs, tablet and smartphone screens, has agreed to buy Britain's AZ Electronic Materials for $2.6...
FRANKFURT, Dec 5 (Reuters) - German diversified chemicals and pharmaceuticals group Merck KGaA said it could pursue more acquisitions after launching a takeover offer for Britain's AZ Electronic Materials.
* Offers 403.5 pence/shr, 41 pct premium over 3-month average
FRANKFURT, Dec 5 (Reuters) - Germany's Merck , the world's largest maker of liquid crystals for flat panel displays, said it agreed to buy Britain's AZ Electronic Materials
LONDON, Dec 5 (Reuters) - German drugs and chemicals group Merck KGaA said on Thursday it had agreed to buy AZ Electronic Materials, a maker of specialty chemicals used to make Apple's iPad, for about 1.57 billion pounds ($2.57 billion).
Dec 2 (Reuters) - Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it plans to buy rights to a new schizophrenia treatment from Merck & Co and cut annual operating costs by $500 million in fiscal 2016.